Research
Hormonal
GIP receptor agonism and antagonism both lead to weight reduction.
Both GIP receptor agonists and antagonists could be explored for obesity treatment strategies.
StrongSupportsmedium confidence
It details examples of how to reconcile the contradictory findings that both GIP receptor agonism and antagonism cause weight reduction.
Why this rating
The review discusses conflicting data and provides examples from current research.
Source
Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity
Robert H. Gaffey et al. · Expert Opinion on Investigational Drugs · 2024
reviewCited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →